Mar Tintore Subirana I am a Neurologist and Head of Care at the Centre d'Esclerosi Multiple de Catalunya (Cemcat) of the Neurology/Neuroimmunology service of the Vall d'Hebron University Hospital. Since June 2023 I have been Head of Section at the Centre d'Esclerosi Multiple de Catalunya (Cemcat) of the Neurology/Neuroimmunology service of the Vall d'Hebron University Hospital. Since 2021 I have been a professor of Neurology at the University of Vic-Central University of Catalonia (UVic-UCC) and since October 2022 I have been Chair of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS). Institutions of which they are part Main researcher Clinical Neuroimmunology Vall Hebron Institut de Recerca Clinical neuroimmunology General Hospital Responsable Assistencial Multiple Sclerosis Centre of Catalonia Twitter Orcid Email Mar Tintore Subirana Twitter Orcid Email Institutions of which they are part Main researcher Clinical Neuroimmunology Vall Hebron Institut de Recerca Clinical neuroimmunology General Hospital Responsable Assistencial Multiple Sclerosis Centre of Catalonia I am a Neurologist and Head of Care at the Centre d'Esclerosi Multiple de Catalunya (Cemcat) of the Neurology/Neuroimmunology service of the Vall d'Hebron University Hospital. Since June 2023 I have been Head of Section at the Centre d'Esclerosi Multiple de Catalunya (Cemcat) of the Neurology/Neuroimmunology service of the Vall d'Hebron University Hospital. Since 2021 I have been a professor of Neurology at the University of Vic-Central University of Catalonia (UVic-UCC) and since October 2022 I have been Chair of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS).
I have developed in particular the study of prognostic factors, multiple sclerosis of the child and adolescent, as well as family planning in women with multiple sclerosis. I am currently a member of the Advisory Ethics Committee (CEA) of the Vall d'Hebron University Hospital. I have published more than 260 articles in national and international journals and am a regular reviewer of indexed journals both national and international. My factor H is currently 60 and until May 2023 my work has received 15,464 citations.
Projects Incorporació Dr. Manuel Comabella a la RETICS en Esclerosis Múltiple IP: Manuel Comabella Lopez Collaborators: Jaume Sastre Garriga, Jordi Rio Izquierdo, Ingrid Galán Cartaña, Rosalia Horno Ocaña, Herena Eixarch Ahufinger, Mar Tintore Subirana, Carmen Espejo Ruiz, Angela Vidal Jordana, Mireia Castillo Juarez Funding agency: Instituto de Salud Carlos III Funding: 225500 Reference: RD16/0015/0004 Duration: 01/01/2017 - 31/12/2022 Diagnostic and prognostic biomarkers in pediatric multiple sclerosis and related demyelinating disorders IP: Mar Tintore Subirana Collaborators: Cristina Auger Acosta, Alex Rovira Cañellas, Mireia del Toro Riera, Angela Vidal Jordana, Luciana Midaglia Fernandez, Georgina Arrambide García Funding agency: Fundació La Marató de TV3 Funding: 100000 Reference: 20141831 Duration: 22/05/2015 - 22/11/2018 Neuroimmunologia Clínica. Centre d'Esclerosi Múltiple de Catalunya (CEMCAT( (GRC) IP: Xavier Montalban Gairín Collaborators: Susana Otero Romero, Carlos Nos Llopis, Sunny Malhotra Sareen, José Ant. Graells Salvador, Jaume Sastre Garriga, Jordi Rio Izquierdo, Ingrid Galán Cartaña, Rosalia Horno Ocaña, Manuel Comabella Lopez, Margarida Capell Maymo, Silvia Soler García, Carmen Tur Gomez, Jordi Barquinero Mañez, Herena Eixarch Ahufinger, Carme Santoyo Medina, Oriol Nualart Mundo, Mar Tintore Subirana, M Jesus Arevalo Navines, Dunia Muñoz Valdivielso, Carmen Espejo Ruiz, Sergio Vergara Ruiz, Luciana Midaglia Fernandez, Joaquin Castillo Justribo, Milagros Fraga Pereira, Breogan Rodriguez Acevedo, Mireia Castillo Juarez, Nicolás Miguel Fissolo, Georgina Arrambide García Funding agency: Agència Gestió Ajuts Universitaris i de Recerca Funding: 50000 Reference: 2014 SGR 1082 Duration: 01/01/2014 - 31/12/2016 Intensificació IP: Mar Tintore Subirana Collaborators: Angela Vidal Jordana, Miriam Izquierdo Sans Funding agency: Instituto de Salud Carlos III Funding: 30000 Reference: INT13/00302 Duration: 01/01/2014 - 31/12/2014 Pagination First page « Previous page ‹ Page 1 Page 2 Current page 3 Page 4 Page 5 … Next page › Last page »
